Our first paper has now been published in the BMJ Open Respiratory Journal:

• Fisher AJ, White M, Goudie N, et al. Extracorporeal photopheresis (ECP) in the treatment of chronic lung allograft dysfunction (CLAD): a prospective, multicentre, open-label, randomised controlled trial studying the addition of ECP to standard care in the treatment of bilateral lung transplant patients with CLAD (E-CLAD UK). BMJ Open Respiratory Research 2024; 11:e001995. doi: 10.1136/bmjresp-2023-001995.

The following publications may also be of interest:

• Chambers DC, Cherikh WS, Goldfarb SB, et al. The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-fifth adult lung and heart-lung transplant report-2018; Focus theme: Multiorgan Transplantation. Journal of Heart and Lung Transplantation 2018; 37(10):1169-83.
• Verleden GM, Glanville AR, Lease ED, et al. Chronic lung allograft dysfunction: Definition, diagnostic criteria, and approaches to treatment-A consensus report from the Pulmonary Council of the ISHLT. Journal of Heart and Lung Transplantation. 2019 May; 38(5):493-503.
• Alfred A, Taylor PC, Dignan F, et al. The role of extracorporeal photopheresis in the management of cutaneous T-cell lymphoma, graft-versus-host disease and organ transplant rejection: a consensus statement update from the UK Photopheresis Society. British Journal of Haematology. 2017; 177(2):287-310.
• Hachem R, Corris P. Extracorporeal Photopheresis for Bronchiolitis Obliterans Syndrome after Lung Transplantation. Transplantation. 2018 Jul; 102(7):1059-1065.
• Lamioni A, Parisi F, Isacchi G, et al. The immunological effects of extracorporeal photopheresis unraveled: induction of tolerogenic dendritic cells in vitro and regulatory T cells in vivo. Transplantation. 2005; 79(7):846-50.